PLYMOUTH
MEETING, Pa., Nov. 6, 2024
/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company
focused on developing and commercializing DNA medicines
to help treat and protect people from HPV-associated diseases,
cancer, and infectious diseases, today announced that third quarter
2024 financial results will be released after the market close on
November 14, 2024. Following the
release, INOVIO will host a live conference call and webcast at
4:30 p.m. ET to discuss financial
results and provide a general business update.
The live webcast will be available online
at http://ir.inovio.com/events-and-presentations/default.aspx.
This is a listen-only event but will include a live Q&A with
analysts. The webcast will be archived and available for replay for
90 days following the event.
About INOVIO
INOVIO is a biotechnology
company focused on developing and commercializing DNA medicines to
help treat and protect people from HPV-related
diseases, cancer, and infectious diseases. INOVIO's
technology optimizes the design and delivery of innovative
DNA medicines that teach the body to manufacture its own
disease-fighting tools. For more information, visit
www.inovio.com.
Contacts
Media: Jennie Willson
(267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267)
440-4298 thomas.hong@inovio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2024-financial-results-on-november-14-2024-302297260.html
SOURCE INOVIO Pharmaceuticals, Inc.
